Bristol-Myers Squibb Awards Immunicon New Research Services Agreement for Oncology Biomarker Development.

Business Wire › June 01, 2007

Linked as:

Extract

Bristol-Myers Squibb Awards Immunicon New Research Services Agreement for Oncology Biomarker Development.

HUNTINGDON VALLEY, Pa. -- Immunicon Corporation (NASDAQ-GM:IMMC) announced today that the Company entered into a Research Services Agreement with Bristol-Myers Squibb (BMS) involving protein and molecular targets associated wi...

See the full content of this document

Sponsored links


Related topics

Related searches

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

  • Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

Schaeffer s S&P 500 Index Hot Stocks Features Teradyne Amgen Maytag Yahoo! and Intel. | PURE Bioscience Reports Third Quarter Results; Builds Foundation for Accelerated Revenues in S... | paul d colasono has been named chief financial officer for franklin credit management corporation in new york. | Energy Overview. | Decisión nº N°456-06 de Tribunal Segundo de Primera Instancia en funciones de Control de Merida Extensión El Vigia de October 05 2006 | Decisión nº 6C-2380-06 de Tribunal Sexto de Control Los Teques de Miranda, de September 29, 2006 | Decisión de Tribunal Tercero de Primera Instancia en funciones de Control de Merida Extensión El Vigia de July 31 2006 | decisión de tribunal sexto de primera instancia en funciones de control de merida extensi...